ContractAsset Purchase Agreement • November 6th, 2017 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
LICENSE AND COLLABORATION AGREEMENT by and between Seattle Genetics, Inc. and Genmab A/S Effective as of: October 7, 2011License and Collaboration Agreement • November 6th, 2017 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances)
SEATTLE GENETICS, INC., a Delaware corporation, having its principal place of business at 21823 30th Drive S.E., Bothell, Washington 98021 (hereinafter referred to as “SGI”)
ASSIGNMENT AND ASSUMPTION OF PURCHASE AGREEMENTAssignment and Assumption of Purchase Agreement • November 6th, 2017 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances)
This ASSIGNMENT AND ASSUMPTION OF PURCHASE AGREEMENT (“Assignment”) is made as of July 30, 2017 between ZymoGenetics, Inc., a Washington corporation (“Assignor”), and Seattle Genetics, Inc., a Delaware corporation (“Assignee”), and is entered into with reference to the following facts:
PURCHASE AGREEMENT (Monte Villa Parkway Research Center, Bothell, Washington)Purchase Agreement • November 6th, 2017 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
This property is free of encumbrances created or suffered by Grantor, except as specifically set forth in the attached Exhibit “B” attached hereto and made a part hereof. The foregoing conveyance is made subject to that certain Purchase Agreement dated as of June 16, 2017 by and between Grantor and Grantee.
